ATLANTA, GA / ACCESS Newswire / March 10, 2026 / The Arthritis Foundation is preparing for its 2026 Cycling Experiences, featuring the Carolina Hills Classic Bike Tour, May 14-17, the California Coast ...
Thyroid disorders may influence uric acid levels and increase gout risk. An expert explains the metabolic link, symptoms to watch for, and why timely diagnosis matters.
LeBron James is the only player on the Lakers’ injury report, but not for the reason you’d imagine. His left elbow contusion is no longer listed but, instead, a right hip contusion has been added.
Bristol Myers Squibb Company on Friday won U.S. approval for its oral drug Sotyktu to treat adults with active psoriatic arthritis. The decision gives patients another option for joint and skin ...
The approval was based on data from the POETYK PsA-1 and POETYK PsA-2 trials, which evaluated the efficacy and safety of deucravacitinib in adults aged 18 years and older with active PsA.
FDA approval introduces first-in-class, once-daily oral TYK2 inhibition for active psoriatic arthritis, expanding deucravacitinib beyond its 2022 plaque psoriasis indication. POETYK PsA-1 and PsA-2 ...
The developers of sustained acoustic medicine technology and the sam® wearable ultrasound device continue mission of ...
In 2019, BMS made a big bet on Sotyktu by deciding to keep the then-pipeline asset despite its pending acquisition of Celgene. Based on that decision, BMS sold its mega-blockbuster Otezla to Amgen for ...
The FDA has approved deucravacitinib for adults with active psoriatic arthritis, according to a press release from Bristol ...
Exposure to fine particulate matter and traffic-related gaseous pollutants were associated with an increased risk for late-onset RA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results